Increased levels of CCR7 ligands in carotid atherosclerosis: different effects in macrophages and smooth muscle cells
Open Access
- 11 February 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 102 (1), 148-156
- https://doi.org/10.1093/cvr/cvu036
Abstract
The homeostatic chemokines, CCL19 and CCL21 and their receptor CCR7, have recently been linked to atherogenesis. We investigated the expression of CCL19/CCL21/CCR7 in carotid atherosclerosis as well as the ability of these chemokines to modulate lipid accumulation in macrophages and vascular smooth muscle cell (SMC) phenotype. Our major findings were: (i) patients with carotid atherosclerosis (n = 158) had increased plasma levels of CCL21, but not of CCL19, compared with controls (n = 20), with particularly high levels in symptomatic (n = 99) when compared with asymptomatic (n = 59) disease. (ii) Carotid plaques showed markedly increased mRNA levels of CCL21 and CCL19 in symptomatic (n = 14) when compared with asymptomatic (n = 7) patients, with CCR7 localized to macrophages and vascular SMC (immunohistochemistry). (iii) In vitro, CCL21, but not CCL19, increased the binding of modified LDL and promoted lipid accumulation in THP-1 macrophages. (iv) CCL19, but not CCL21, increased proliferation and release and activity of matrix metalloproteinase (MMP) 1 in vascular SMC. (v) The differential effects of CCL19 and CCL21 in macrophages and SMC seem to be attributable to divergent signalling pathways, with CCL19-mediated activation of AKT in SMC- and CCL21-mediated activation of extracellular signal-regulated kinase 1/2 in macrophages. CCL19 and CCL21 are up-regulated in carotid atherosclerosis. The ability of CCL21 to promote lipid accumulation in macrophages and of CCL19 to induce proliferation and MMP-1 expression in vascular SMC could contribute to their pro-atherogenic potential.This publication has 36 references indexed in Scilit:
- oxLDL Downregulates the Dendritic Cell Homing Factors CCR7 and CCL21Mediators of Inflammation, 2012
- Role of C-C chemokine receptor type 7 and its ligands during neuroinflammationJournal of Neuroinflammation, 2012
- The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaquesNature Immunology, 2012
- Statins Promote the Regression of Atherosclerosis via Activation of the CCR7-Dependent Emigration Pathway in MacrophagesPLOS ONE, 2011
- Chemokines: established and novel targets in atherosclerosisEMBO Molecular Medicine, 2011
- SDF-1α Induction in Mature Smooth Muscle Cells by Inactivation of PTEN Is a Critical Mediator of Exacerbated Injury-Induced Neointima FormationArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe–/– mice during disease regressionJCI Insight, 2011
- LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regressionJCI Insight, 2010
- Pulmonary expression of CXC chemokine ligand 13, CC chemokine ligand 19, and CC chemokine ligand 21 is essential for local immunity to influenzaProceedings of the National Academy of Sciences of the United States of America, 2007
- Enhanced Expression of the Homeostatic Chemokines CCL19 and CCL21 in Clinical and Experimental AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2007